Study designs in clinical research

Nephron - Clinical Practice

Volumn 113, Issue 3, 2009, Pages

  Noordzij, Marlies ^a   Dekker, Friedo W ^b   Zoccali, Carmine ^c   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Epidemiology; Observational studies; Randomized controlled trials; Study design

Indexed keywords

ACETYLSALICYLIC ACID;

CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; CREATININE CLEARANCE; ETHICS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MICROALBUMINURIA; NEPHROLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

BIOMEDICAL RESEARCH; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 68749111732     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235610     Document Type: Short Survey

References (12)

1. Biberstein M, Parker BA: Enema-induced hyperphosphatemia. Am J Med 1985; 79: 645-646.
2. Rohack JJ, Mehta BR, Subramanyam K: Hyperphosphatemia and hypocalcemic coma associated with phosphate enema. South Med J 1985; 78: 1241-1242.
3. Food and Drug Administration science background paper: Acute phosphate nephropathy and renal failure associated with the use of oral sodium phosphate bowel cleansing products: Http://www.fda.gov/cder/drug/infopage/OSP-solution/ backgrounder.htm.
4. Vandenbroucke JP: In defense of case reports and case series. Ann Intern Med 2001; 134: 330-334.
5. Bello AK, Peters J, Wight J, de Zeeuw D, El Nahas M: A population-based screening for microalbuminuria among relatives of CKD patients: The Kidney Evaluation and Awareness Program in Sheffield (KEAPS). Am J Kidney Dis 2008; 52: 434-443.
6. Ibanez L, Morlans M, Vidal X, Martinez MJ, Laporte JR: Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney Int 2005; 67: 2393-2398.
7. Mapes DL, Lopes AA, Satayathum S, Mc-Cullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339-349. (Pubitemid 36714189)
8. Dialysis Outcomes and Practice Patterns Study (DOPPS) website: Http://www.dopps.org.
9. Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW: The valuable contribution of observational studies to nephrology. Kidney Int 2007; 72: 671-675.
10. Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW: The randomized clinical trial: An unbeatable standard in clinical research? Kidney Int 2007; 72: 539-542.
11. Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C: Bias in clinical research. Kidney Int 2008; 73: 148-153.
12. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.